Lisinopril and Hydrochlorothiazide

Product NDC
55700-799
11-digit product format
557000799
Labeler code
55700
Product ID
55700-799_68de9422-ee46-4b0e-a80d-81df6a2a4314
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
Quality Care Products, LLC
Application
ANDA076194
Marketing category
ANDA
Marketing start
2019-10-11
Marketing end
0000-00-00
Substance
LISINOPRIL; HYDROCHLOROTHIAZIDE
Active strength
20 mg/1; mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
E7199S1YWRLISINOPRIL83915-83-7LISINOPRIL
0J48LPH2THHYDROCHLOROTHIAZIDE58-93-5HYDROCHLOROTHIAZIDE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
55700-799-305570007993030 TABLET in 1 BOTTLE, PLASTIC (55700-799-30) 30 tablet2019-10-110000-00-00NoNoCurrent
55700-799-905570007999090 TABLET in 1 BOTTLE, PLASTIC (55700-799-90) 90 tablet2020-08-140000-00-00NoNoCurrent